PNLIP
MOLECULAR TARGETpancreatic lipase
PNLIP (pancreatic lipase) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PNLIP
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | orlistat | 4.23 | 68 |
| 2 | oleanonic acid | 3.14 | 22 |
| 3 | sanggenon c | 2.20 | 8 |
| 4 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 0.69 | 1 |
| 5 | Quercetin | 0.69 | 1 |
| 6 | rafoxanide | 0.69 | 1 |
About PNLIP as a Drug Target
PNLIP (pancreatic lipase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented PNLIP interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PNLIP inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.